Ronald Leonard Bourgeois
Ronald Leonard Bourgeois publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism, on topics such as Lipoproteins and Cardiovascular Health, Diabetes Treatment and Management and Heart Failure Treatment and Management.
- World rank
- #376,526 of 7,710,434 ranked researchers
- Rank in Canada
- #13,113 of 183,316
- Works
- 19
- Citations
- 2.8k
- Citations per work
- 147.5
What does Ronald Leonard Bourgeois research?
Ronald Leonard Bourgeois's work is mostly in Medicine (84%), Biochemistry, Genetics and Molecular Biology (4%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1684.0%
- Medicine1684.0%
- Life Sciences28.0%
- Everything else28.0%
- 1Cardiology and Cardiovascular Medicine34% of their works
- 2Surgery26% of their works
- 3Endocrinology, Diabetes and Metabolism18% of their works
- 4Epidemiology6% of their works
- 5Cancer Research4% of their works
- 6Immunology4% of their works
Research topics
- Lipoproteins and Cardiovascular Health
- Diabetes Treatment and Management
- Heart Failure Treatment and Management
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac pacing and defibrillation studies
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Coronary Interventions and Diagnostics
- Protease and Inhibitor Mechanisms
Which keywords describe Ronald Leonard Bourgeois's research?
The keywords of their largest research topics: Heart Failure, Cholesterol-lowering, Statins, Cardiovascular Disease, Percutaneous Coronary Intervention, Atherosclerosis, Cardiovascular Outcomes and Type 2 Diabetes.
- Tissue Inhibitors of Metalloproteinases
- Myocardial Revascularization
- Implantable Cardioverter-Defibrillator
- Coronary Stents
- Guidelines
- Clopidogrel
- Type 2 Diabetes
- Atherosclerosis
- Cardiovascular Disease
- Cholesterol-lowering
- Heart Failure
- Statins
- Percutaneous Coronary Intervention
- Cardiovascular Outcomes
- Aspirin
- Diagnosis
- Cardiac Resynchronization Therapy
- Diabetes
- Metabolic Syndrome
- Matrix Metalloproteinases
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Heart Failure123 topics
- Cholesterol-lowering81 topic
- Statins81 topic
- Cardiovascular Disease72 topics
- Percutaneous Coronary Intervention72 topics
- Atherosclerosis62 topics
- Cardiovascular Outcomes51 topic
- Type 2 Diabetes51 topic
- Aspirin41 topic
- Clopidogrel41 topic
- Diagnosis41 topic
- Guidelines41 topic
- Cardiac Resynchronization Therapy31 topic
- Coronary Stents31 topic
- Diabetes31 topic
- Implantable Cardioverter-Defibrillator31 topic
- Metabolic Syndrome31 topic
- Myocardial Revascularization31 topic
- Matrix Metalloproteinases21 topic
- Tissue Inhibitors of Metalloproteinases21 topic
Where does Ronald Leonard Bourgeois work?
Ronald Leonard Bourgeois's main affiliation in the publication record is Canadian VIGOUR Centre, Canada.
How many publications and citations does Ronald Leonard Bourgeois have?
OpenAlex counts 19 works and 2,802 citations for Ronald Leonard Bourgeois, an h-index of 14, ranking #376,526 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ronald Leonard Bourgeois. Posts are plain text and can be reported.